09/10/2026
The Effectiveness of Cyproheptadine as a Treatment Option for Cats with Eosinophilic Airway Inflammation.
Based on the four relevant studies found there is no current evidence to support that cyproheptadine monotherapy has any immediate benefit over no treatment for feline eosinophilic airway inflammation, and its use is not supported for this indication. While the strength of this evidence is moderate further studies are warranted in cats with naturally occurring eosinophilic airway disease to draw definitive conclusions about the effects of cyproheptadine.
In this Knowledge Summary Jillian Seeman and co-authors from Midwestern University Animal Health Institute explore this clinical question and what the evidence shows.
What do you do in practice? Read the full summary here: https://bit.ly/KSFelineAirway